News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
655,015 Results
Type
Article (60333)
Company Profile (176)
Press Release (594484)
Multimedia
Podcasts (166)
Webinars (28)
Section
Business (171555)
Career Advice (2671)
Deals (31948)
Drug Delivery (155)
Drug Development (76709)
Employer Resources (171)
FDA (16742)
Job Trends (13783)
News (305306)
Policy (32322)
Tag
2027 BioCapital Elite (1)
2027 BioMidwest Elite (1)
2027 Biotech Bay Standard (1)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (3)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (2742)
Academic (1)
Accelerated approval (45)
Adcomms (37)
Allergies (159)
Alliances (44245)
ALS (197)
Alzheimer's disease (1843)
Antibody-drug conjugate (ADC) (390)
Approvals (16956)
Artificial intelligence (622)
Autoimmune disease (236)
Automation (49)
Bankruptcy (326)
Best Places to Work (10580)
BIOSECURE Act (23)
Biosimilars (212)
Biotechnology (108)
Bladder cancer (181)
Brain cancer (69)
Breast cancer (688)
Cancer (5380)
Cardiovascular disease (479)
Career advice (2268)
Career pathing (44)
CAR-T (303)
CDC (71)
Celiac Disease (1)
Cell therapy (836)
Cervical cancer (40)
Clinical research (65879)
Collaboration (1912)
Company closure (6)
Compensation (1275)
Complete response letters (91)
COVID-19 (2883)
CRISPR (104)
C-suite (989)
Cystic fibrosis (151)
Data (7012)
Decentralized trials (3)
Denatured (45)
Depression (172)
Dermatology (57)
Diabetes (571)
Diagnostics (6477)
Digital health (44)
Diversity (10)
Diversity, equity & inclusion (45)
Drug discovery (297)
Drug pricing (232)
Drug shortages (34)
Duchenne muscular dystrophy (282)
Earnings (69253)
Editorial (71)
Employer branding (22)
Employer resources (153)
Events (97390)
Executive appointments (1042)
FDA (20211)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (14)
Frontotemporal dementia (29)
Funding (1582)
Gene editing (221)
Generative AI (57)
Gene therapy (711)
GLP-1 (1173)
Government (4575)
Grass and pollen (8)
Guidances (395)
Healthcare (17413)
HIV (76)
Huntington's disease (57)
IgA nephropathy (96)
Immunology and inflammation (324)
Immuno-oncology (87)
Indications (149)
Infectious disease (3210)
Inflammatory bowel disease (203)
Inflation Reduction Act (15)
Influenza (133)
Intellectual property (266)
Interviews (493)
IPO (15229)
IRA (58)
Job creations (3528)
Job search strategy (1863)
JPM (70)
Kidney cancer (19)
Labor market (94)
Layoffs (641)
Leadership (44)
Legal (7621)
Liver cancer (105)
Longevity (28)
Lung cancer (719)
Lymphoma (406)
Machine learning (51)
Management (58)
Manufacturing (933)
MASH (190)
Medical device (12919)
Medtech (12992)
Mergers & acquisitions (17873)
Metabolic disorders (1546)
mRNA (207)
Multiple sclerosis (174)
NASH (24)
Neurodegenerative disease (418)
Neuropsychiatric disorders (112)
Neuroscience (3310)
Neurotech (2)
NextGen: Class of 2026 (6005)
Non-profit (4252)
Now hiring (63)
Obesity (761)
Opinion (310)
Ovarian cancer (177)
Pain (235)
Pancreatic cancer (258)
Parkinson's disease (358)
Partnered (33)
Patents (551)
Patient recruitment (590)
Peanut (58)
People (54350)
Pharmaceutical (49)
Pharmacy benefit managers (34)
Phase 1 (19865)
Phase 2 (28729)
Phase 3 (22655)
Pipeline (7069)
Policy (361)
Postmarket research (2577)
Preclinical (8692)
Press Release (66)
Prostate cancer (281)
Psychedelics (61)
Radiopharmaceuticals (297)
Rare diseases (1087)
Real estate (5227)
Recruiting (69)
Regulatory (25253)
Reports (50)
Research institute (2544)
Resumes & cover letters (432)
Rett syndrome (33)
RNA editing (21)
RSV (89)
Schizophrenia (171)
Series A (271)
Series B (197)
Service/supplier (10)
Sickle cell disease (113)
Special edition (29)
Spinal muscular atrophy (173)
Sponsored (51)
Startups (3369)
State (2)
Stomach cancer (21)
Supply chain (121)
Tariffs (101)
The Weekly (119)
Vaccines (1192)
Venture capital (108)
Weight loss (524)
Women's health (100)
Worklife (23)
Date
Today (160)
Last 7 days (704)
Last 30 days (2779)
Last 365 days (30354)
2026 (8027)
2025 (30535)
2024 (34589)
2023 (38484)
2022 (48937)
2021 (53073)
2020 (50618)
2019 (42469)
2018 (32185)
2017 (31517)
2016 (30363)
2015 (34248)
2014 (27543)
2013 (23430)
2012 (23839)
2011 (24237)
2010 (22065)
Location
Africa (867)
Alabama (82)
Alaska (7)
Arizona (286)
Arkansas (12)
Asia (39357)
Australia (6975)
California (12022)
Canada (3140)
China (1203)
Colorado (491)
Connecticut (528)
Delaware (352)
Europe (94922)
Florida (1799)
Georgia (397)
Hawaii (4)
Idaho (49)
Illinois (950)
India (79)
Indiana (565)
Iowa (23)
Japan (485)
Kansas (118)
Kentucky (37)
Louisiana (37)
Maine (80)
Maryland (1472)
Massachusetts (8739)
Michigan (345)
Minnesota (669)
Mississippi (5)
Missouri (141)
Montana (26)
Nebraska (24)
Nevada (134)
New Hampshire (76)
New Jersey (3276)
New Mexico (27)
New York (3196)
North Carolina (1573)
North Dakota (10)
Northern California (5977)
Ohio (359)
Oklahoma (20)
Oregon (40)
Pennsylvania (2342)
Puerto Rico (21)
Rhode Island (44)
South America (1223)
South Carolina (76)
South Dakota (1)
Southern California (4733)
Tennessee (188)
Texas (1864)
United States (42701)
Utah (329)
Vermont (1)
Virginia (296)
Washington D.C. (81)
Washington State (968)
West Virginia (4)
Wisconsin (130)
Wyoming (2)
655,015 Results for "scient x groupe s a".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Faron Announces Phase II BEAM-X IIT Led by the Nordic AML Group Evaluating Bexmarilimab in Post-Transplant AML
February 19, 2026
·
6 min read
Rare diseases
Rare Disease Groups Lobby for Regulatory Expediency as Makary Defends ‘Rigorous’ Approach
This week’s Capitol Hill meetings come on the heels of rejections of ultra-rare disease drugs developed by Biohaven and Saol Therapeutics. Physicians and patient groups implored the FDA to expedite these treatments.
February 27, 2026
·
6 min read
·
Heather McKenzie
Press Releases
Catalyst MedTech Announces Acquisition of X3D
April 2, 2026
·
3 min read
Press Releases
Vial Doses First Patient for Phase 1 Trial of Vial’s IL-13 x TSLP, a Novel Bispecific Antibody
March 3, 2026
·
1 min read
Press Releases
Byonyks X1: Revolutionizing Dialysis - Now FDA Cleared and Planning to start Patients in the U.S.
February 4, 2026
·
3 min read
Press Releases
Xaira Therapeutics Launches X-Cell, Its First Virtual Cell Model, Trained on the Largest-Ever Genome-Wide Perturbation Dataset, X-Atlas/Pisces
March 17, 2026
·
3 min read
Press Releases
Byonyks X1: Revolutinizing Dialysis - Now FDA Cleared and Planning to start Patients in the U.S.
February 3, 2026
·
3 min read
Gene therapy
Liver Toxicities Force Pause on Two Dose Groups of UniQure’s Mid-Stage Fabry Study
The gene therapy uses an AAV vector to restore healthy levels of the alpha-galactosidase enzyme, which is rendered dysfunctional in patients with Fabry disease, leading to the toxic build-up of lipids in cells.
February 9, 2026
·
1 min read
·
Tristan Manalac
Press Releases
Secura Bio Announces Participation in Gilmartin Group’s 2026 Corporate Access Event in San Francisco
December 24, 2025
·
4 min read
Press Releases
Terray’s New EMMI Predict Model Sets an Industry Performance Standard – Delivering Best-In-Class Accuracy, 26x Faster
February 12, 2026
·
4 min read
1 of 65,502
Next
